The framing in this article seems wildly out of step with the evidence. As far as I can tell, the benefit to CF sufferers from Orkambi is pretty small, it's not a "wonder drug"https://www.dailymail.co.uk/health/article-6964037/Please-dont-let-die-Three-cystic-fibrosis-sufferers-beg-NHS-fund-wonder-drug.html …
-
-
You’re not looking at it from the right perspective Gideon...
-
I assume you mean profit, but honestly I'm not sure? Like, is a 3% improvement for CF worth the enormous cost? It doesn't appear to improve QoL so I'd guess no, and I really can't see how you'd justify 'wonder drug'???
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.